Trial Information

Summary: Mild to Moderate Alzheimer's disease

We are conducting a clinical research study for volunteers diagnosed with probable Alzheimer's disease that have a reliable caregiver to be involved in the study. This study tests the safety and effectiveness of 3 doses of an investigational drug compared to placebo. This study lasts 83 weeks with 15 visits and you will receive 6 infusions every 13 weeks. The investigational drug is aimed at slowing the progression of the disease.

Study Criteria:

• Age 50-88
• Diagnosed with probable Alzheimer's (mild to moderate)
• Living at home or in a community dwelling with a caregiver willing to accompany the patient to all visits
• Stable doses of medications for 30 days
• Willing to undergo ApoE testing and agree to disclose of ApoE4 status
• No other significant neurological disease other than Alzheimer's, that may affect cognition
• No history of clinically evident stroke or seizures
• Weight must be less than 264lbs
• Cannot have donated blood within the last 90 days
• No excessive smoking (>20 per day)
• No women of childbearing potential
• Must be able to have MRI scan
• No heart attack within 2 years or cancer within 5 years
• No history of alcohol or drug abuse within the last 2 years
• No investigational drug within the last 60 days

If eligible, you will receive investigational drug and study-related medical care at no cost. Reimbursement for time and travel may also be available

For additional information about this study or to enroll, visit our website: www.clinicaltrialsinc.com

If you would like to learn more about participating in this study, please send an e-mail message using the form below.